Financhill
Back

CureVac NV 10K Form

Buy
52

CVAC
CureVac NV

Last Price:
$3.57
Seasonality Move:
-4.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CVAC News And Ratings

See the #1 stock for the next 7 days that we like better than CVAC

CVAC Financial Statistics

Sales & Book Value

Annual Sales: $579.3M
Cash Flow: $381.2M
Price / Cash Flow: 8.86
Annual Sales: $3.61
Price / Book: 1.11

Profitability

EPS (TTM): 0.54840
Net Income (TTM): $123.7M
Gross Margin: $464.7M
Return on Equity: 21.3%
Return on Assets: 15.24%

CureVac NV Earnings Forecast

Key CureVac NV Financial Ratios

  • The Gross Profit Margin over the past 7 years for CVAC is 80.23%.
  • The Selling, General & Administrative Expenses for CVAC have been equal to 11.36% of Gross Profit Margin.
  • The Research & Development expenses have been 28.59% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of CVAC is 30.30% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

CureVac NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CVAC
Website: curevac.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.2
Quick Ratio: 6.1

Price-to-Earnings

Trailing P/E Ratio: 4.57
Forward P/E Ratio: 0

CVAC Technical Analysis vs Fundamental Analysis

Buy
52
CureVac NV (CVAC) is a Buy

Is CureVac NV a Buy or a Sell?

  • CureVac NV stock is rated a Buy
    The current CureVac NV [CVAC] share price is $3.56. The Score for CVAC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.